Viewing StudyNCT03157128

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 10:05 AM
Last Modification Date: 2024-10-26 @ 12:24 PM
Study NCT ID: NCT03157128
Status: RECRUITING
Last Update Posted: 2024-03-04
First Post: 2017-05-09
Brief Title: A Study of Selpercatinib LOXO-292 in Participants With Advanced Solid Tumors RET Fusion-Positive Solid Tumors and Medullary Thyroid Cancer LIBRETTO-001
Sponsor: Loxo Oncology Inc
Organization: Eli Lilly and Company
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Any Solid Tumor
Non-Small Cell Lung Cancer
Medullary Thyroid Cancer
Colon Cancer
Keywords:
Name View
neo-adjuvant treatment in early stage NSCLC View
LOXO-292 View
KIF5B-RET View
M918T View
CCDC6-RET View
RET-PTC1 View
NCOA4-RET View
RET-PTC View
RET-PTC3 View
RET-PTC4 View
PRKAR1A-RET View
RET-PTC2 View
GOLGA5-RET View
RET-PTC5 View
ERC1-RET View
KTN1-RET View
RET-PTC8 View
HOOK3-RET View
PCM1-RET View
TRIM24-RET View
RET-PTC6 View
TRIM27-RET View
TRIM33-RET View
RET-PTC7 View
AKAP13-RET View
FKBP15-RET View
SPECC1L-RET View
TBL1XR1-RET View
BCR-RET View
FGRF1OP-RET View
RFG8-RET View
RET-PTC9 View
ACBD5-RET View
MYH13-RET View
CUX1-RET View
KIAA1468-RET View
FRMD4A-RET View
SQSTM1-RET View
AFAP1L2-RET View
PPFIBP2-RET View
EML4-RET View
PARD3-RET View
G533C View
C609F View
C609G View
C609R View
C609S View
C609Y View
C611F View
C611G View
C611S View
C611Y View
C611W View
C618F View
C618R View
C618S View
C620F View
C620R View
C620S View
C630R View
C630Y View
D631Y View
C634F View
C634G View
C634R View
C634S View
C634W View
C634Y View
K666E View
E768D View
L790F View
V804L View
V804M View
A883F View
S891A View
R912P View
CLIP1-RET View
Y806C View
RET fusion View
RET alteration View
RET mutation View
RET rearrangement View
RET translocation View
Neoplasms by Site View
Neoplasms View
Non-Small Cell Lung Cancer View
Lung Neoplasms View
Carcinoma Non-Small-Cell Lung View
Cancer of Lung View
Cancer of the Lung View
Lung Cancer View
Neoplasms Lung View
Neoplasms Pulmonary View
Pulmonary Cancer View
Pulmonary Neoplasms View
Respiratory Tract Neoplasms View
Lung Diseases View
Respiratory Tract Diseases View
Carcinoma Bronchogenic View
Bronchial Neoplasms View
Medullary Thyroid Cancer View
Papillary Thyroid Cancer View
Thyroid Diseases View
Thyroid Neoplasms View
Cancer of the Thyroid View
Cancer of Thyroid View
Neoplasms Thyroid View
Thyroid Ademona View
Thyroid Cancer View
Thyroid Carcinoma View
Endocrine System Diseases View
Endocrine Gland Neoplasms View
Head and Neck Neoplasms View
Thoracic Neoplasms View
CNS tumor View
Primary CNS tumor View
Cancer of Colon View
Cancer of the Colon View
Colon Cancer View
Colon Neoplasms View
Colonic Cancer View
Neoplasms Colonic View
Malignant tumor of Breast View
Mammary Cancer View
Mammary Carcinoma Human View
Mammary Neoplasm Human View
Neoplasms Breast View
Tumors Breast View
Human Mammary Carcinoma View
Malignant Neoplasm of Breast View
Breast Carcinoma View
Breast Tumors View
Cancer of the Breast View
Breast Neoplasms View
Breast Cancer View
RET Inhibitor View
MTC View
NSCLC View
selpercatinib View